Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas
Takao Hashimoto, Tomoo Ohashi, Daisuke Watanabe, Syunichi Koyama, Hiroaki Namatame, Hitoshi Izawa, Rei Haraoka, Hirofumi Okada, Norio Ichimasu, Jiro Akimoto, Jo Haraoka, Takao Hashimoto, Tomoo Ohashi, Daisuke Watanabe, Syunichi Koyama, Hiroaki Namatame, Hitoshi Izawa, Rei Haraoka, Hirofumi Okada, Norio Ichimasu, Jiro Akimoto, Jo Haraoka
Abstract
Background: Chronic subdural hematoma (CSDH) is generally treated by burr hole irrigation. However, sometimes repeated recurrence is observed, and treatment may consequently become difficult. We examined the efficacy of embolization of the middle meningeal artery (MMA) for such cases.
Methods: We considered embolization of the MMA for three patients who had refractory CSDH with repeated recurrence and two CSDH patients who were at risk of recurrence and showed signs of recurrence after surgery. A microcatheter was advanced through the MMA as peripherally as possible, and embolization was performed with 15-20% n-butyl-2-cyanoacrylate or 200 μm polyvinyl alcohol particles.
Results: EMBOLIZATION WAS PERFORMED IN THE THREE PATIENTS WHO HAD REFRACTORY CSDH WITH REPEATED RECURRENCE: The procedure was performed after burr hole irrigation of the hematoma in two patients and before the irrigation in one patient. In the two CSDH patients at risk of recurrence, embolization was performed when signs of recurrence appeared. The timing of embolization differed for each patient. However, in all the patients, the hematoma tended to decrease in size, and no recurrence was observed.
Conclusion: Embolization of the MMA is effective for refractory CSDH or CSDH patients with a risk of recurrence, and is considered an effective therapeutic method to stop hematoma enlargement and promote resolution.
Keywords: Chronic subdural hematoma; embolization; middle meningeal artery; recurrence.
Figures
References
- Arbit E, Patterson RH, Jr, Fraser RA. An implantable subdural drain for treatment of chronic subdural hematoma. Surg Neurol. 1981;15:175–7.
- Ishihara H, Ishihara S, Kohyama S, Yamane F, Ogawa M, Sato A, et al. Experience in endovascular treatment of recurrent chronic subdural hematoma. Interv Neuroradiol. 2007;13:141–4.
- Mandai S, Sakurai M, Matsumoto Y. Middle meningeal artery embolization for refractory chronic subdural hematoma: Case report. J Neurosurg. 2000;93:686–8.
- Mino M, Nishimura S, Hori E, Kohama M, Yonezawa S, Midorikawa H, et al. Efficacy of middle meningeal artery embolization in the treatment of refractory chronic subdural hematoma. Surg Neurol Int. 2010;1:78.
- Nagahori T, Nishijima T, Takaku A. Histological study of the outer membrane of chronic subdural hematoma: Possible mechanism for expansion of hematoma cavity. No Shinkei Geka. 1993;21:697–701.
- Robinson RG. Chronic subdural hematoma: Surgical management in 133 patients. J Neurosurg. 1984;61:263–8.
- Shiomi N, Sasajima H, Mineura K. Relationship of postoperative residual air and recurrence in chronic subdural hematoma. No Shinkei Geka. 2001;29:39–44.
- Suzuki K, Sugita K, Akai T, Takahata T, Sonobe M, Takahashi S. Treatment of chronic subdural hematoma by closed-system drainage without irrigation. Surg Neurol. 1998;50:231–4.
- Takahashi K, Muraoka K, Sugiura T, Maeda Y, Mandai S, Gohda Y, et al. Middle Meningeal artery embolization for refractory chronic subdural hematoma: 3 case reports. No Shinkei Geka. 2002;30:535–9.
- Tanaka T, Kaimori M. Histological study of vascular structure between the dura mater and the outer membrane in chronic subdural hematoma in an adult. No Shinkei Geka. 1999;27:431–6.
- Tsukamoto Y, Oishi M, Shinbo J, Fujii Y. Transarterial embolization for refractory bilateral chronic subdural hematomas in a case with dentatorubral-pallidoluysian atrophy. Acta Neurochir. 2011;153:1145–7.
- Tsutsumi K, Maeda K, Iijima A, Usui M, Okada Y, Kirino T. The relationship of preoperative magnetic resonance imaging findings and closed system drainage in the recurrence of chronic subdural hematoma. J Neurosurg. 1997;87:870–5.
Source: PubMed